# FDA recall D-0348-2023

> **RISING PHARMACEUTICALS** · Class II · drug recall initiated 2023-02-15.

## Product

Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

Product was distributed to 16 distributors and 8 wholesalers who may have further distributed the product nationwide.

## Key facts

- **Recall number:** D-0348-2023
- **Recalling firm:** RISING PHARMACEUTICALS
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-02-15
- **Report date:** 2023-03-01
- **Termination date:** 2024-06-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0348-2023

## Citation

> AI Analytics. FDA recall D-0348-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0348-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*